Skip to content

Effect of an Investigational Multi-Purpose Solution on Lens Moisture

Effect of SiH MPDS FID 114675A vs. a Marketed Multi-Purpose Solution on Lens Moisture

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01341990
Enrollment
68
Registered
2011-04-26
Start date
2009-11-30
Completion date
2010-01-31
Last updated
2012-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contact Lens Moisture

Keywords

Contact Lenses, Contact Lens Care, Multi-Purpose Solution

Brief summary

The purpose of the study is to evaluate the effect of an investigational multi-purpose disinfecting solution (MPDS) compared to a marketed multi-purpose solution on the moisture of silicone hydrogel contact lenses.

Interventions

Investigational solution intended for use as a cleaning, rinsing, reconditioning, disinfecting, and storage solution for silicone hydrogel and soft contact lenses

DEVICEReNu Fresh Lens Comfort Multi-Purpose Solution (MPS)

Commercially marketed prodouct indicated for cleaning, removing protein deposits, rinsing, disinfecting, and storing soft contact lenses

Commercially marketed silicone hydrogel contact lenses per habitual prescription for daily wear use, at least 8 hours/day. New pair dispensed at Day 0 (Baseline Visit) and at the conclusion of Day 1 (Visit 2).

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older. * Wears silicone hydrogel contact lenses on a daily wear basis i.e. disinfects lenses every night). * Has successfully worn contact lenses for 5 days, 8 hours per day, prior to baseline visit. * Vision is correctable to 20/30 or better in each eye at distance with study lenses at baseline visit. * Other protocol-specified inclusion criteria may apply.

Exclusion criteria

* Known sensitivity or intolerance to contact lens multi-purpose solutions. * Use of any topical ocular OTC or prescribed topical ocular medications. * History or current ocular infections or ocular inflammatory events. * Ocular surgery within the past year. * Medical condition or use of medication that cause ocular side effects. * Participation in any investigational study within the past 30 days. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Mean Ex-Vivo Advancing Contact AngleDay 1, 8 hoursStudy lens was removed from the eye according to protocol-specified procedures. The OCA15 (Optical Contact Angle) Instrument was used to observe, record, and calculate contact angle measurements. The wetting angle measurement was recorded in degrees (0-180), and a lower wetting angle measurement indicates a more wettable lens.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from 1 US study center.

Participants by arm

ArmCount
FID 114675A
Multi-purpose disinfecting solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses
35
ReNu MultiPlus
Multi-purpose solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses
33
Total68

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event01
Overall StudyTorn Study Lens10
Overall StudyWithdrawal by Subject20

Baseline characteristics

CharacteristicFID 114675AReNu MultiPlusTotal
Age Continuous43.9 years
STANDARD_DEVIATION 9.2
42.8 years
STANDARD_DEVIATION 11.2
43.4 years
STANDARD_DEVIATION 10.2
Region of Enrollment
United States
35 participants33 participants68 participants
Sex: Female, Male
Female
23 Participants22 Participants45 Participants
Sex: Female, Male
Male
12 Participants11 Participants23 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 350 / 33
serious
Total, serious adverse events
0 / 350 / 33

Outcome results

Primary

Mean Ex-Vivo Advancing Contact Angle

Study lens was removed from the eye according to protocol-specified procedures. The OCA15 (Optical Contact Angle) Instrument was used to observe, record, and calculate contact angle measurements. The wetting angle measurement was recorded in degrees (0-180), and a lower wetting angle measurement indicates a more wettable lens.

Time frame: Day 1, 8 hours

Population: Intent to Treat.

ArmMeasureValue (MEAN)Dispersion
FID 114675AMean Ex-Vivo Advancing Contact Angle56.7 DegreesStandard Deviation 21.2
ReNu MultiPlusMean Ex-Vivo Advancing Contact Angle59.2 DegreesStandard Deviation 23.7
Primary

Mean Ex-Vivo Advancing Contact Angle

Study lens was removed from the eye according to protocol-specified procedures. The OCA15 (Optical Contact Angle) Instrument was used to observe, record, and calculate contact angle measurements. The wetting angle measurement was recorded in degrees (0-180), and a lower wetting angle measurement indicates a more wettable lens.

Time frame: Day 8, 16 hours

Population: Intent to treat.

ArmMeasureValue (MEAN)Dispersion
FID 114675AMean Ex-Vivo Advancing Contact Angle59.5 DegreesStandard Deviation 21.2
ReNu MultiPlusMean Ex-Vivo Advancing Contact Angle63.4 DegreesStandard Deviation 17.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026